1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
14 |
15 |
16 |
17 |
18 |
19 |
20 |
21 |
22 |
23 |
24 |
25 |
26 |
27 |
28 |
29 |
30 |
31 |
32 |
33 |
34 |
35 |
36 |
37 |
38 |
39 |
40 |
41 |
42 |
43 |
44 |
45 |
46 |
47 |
48 |
49 |
50 |
51 |
52 |
53 |
54 |
55 |
Pembrolizumab Combo Extends Chemotherapy Benefit in Pancreatic Cancer
Release Date: 11 August 2020
For the clinical trial CheckMate-577 clinical trial, adjuvant nivolumab (Opdivo), was observed to deliver a prolonged disease -free survival in the patients who have been suffering from resected esophageal or gastroesophageal junction cancer when comapffed with place...
Read More
Immune-Related Adverse Events Associated with Immunotherapy Treatment Regimen
Release Date: 11 August 2020
The arrival of immunotherapy has completely revolutionized the concept of treating cancers. Various different therapies available under it attacks the programmed death-1 and programmed death-ligand 1 interaction. In most of the cancer cells, interaction between PD-1 ...
Read More
Novel Points Identification for Treating Blindness – Retina Deattachment
Release Date: 10 August 2020
Premature birth of a baby and development of diabetes in a patient is mostly seen in the cases where oxygen is not able to reach the eyes. The result of such process is ultimate blindness but now this has been targeted by a group of researchers from Medical College o...
Read More
Scientists Identifies Immunotherapy as a Potential Treatment for Pancreatic Tumors
Release Date: 10 August 2020
The COMBAT trial led by HonorHealth Research Institute and the Translational Genomics Research Institute is focused towards conducting clinical trials for immunotherapy benefit for pancreatic cancer. In the respective trial, the enrolled patients were given pembroliz...
Read More
Immunotherapy Protecting the Brain Cells from Aggressive Damage
Release Date: 09 August 2020
Brain cancer is one of the most unexplored types of cancer in the research sector. Now-a-days, a novel treatment that has the potential towards aggressive brain cancer has been found to be effective as the results obtained through the early trials of the same have be...
Read More
Repatha Shows Promising Activity against Low-Density Lipoprotein Cholesterol and Cardiovascular Events
Release Date: 09 August 2020
Metabolic syndromes in today’s generation has been widely observed and diagnosed. An important reason for such high cases of metabolic syndromes in the population is the unhealthy lifestyle that is getting attached to the upbringing. This is a major conern acro...
Read More
LEFTY1 Fueling the Success Rate of Breast Cancer Treatment Success
Release Date: 08 August 2020
An important property that is linked with cancer is that it can exhibit changes in the kinase and phosphatase balances in the body. There are several different types of drugs available in the market that taget kinase activity and several drugs have shown success resu...
Read More
Phosphatase Cascade Offering Promising Results for Different Cancer Indications
Release Date: 08 August 2020
An important property that is linked with cancer is that it can exhibit changes in the kinase and phosphatase balances in the body. There are several different types of drugs available in the market that taget kinase activity and several drugs have shown success resu...
Read More
CAR-T Cells Identifies Hodgkin’s Lymphoma Cells as Novel Target
Release Date: 07 August 2020
Complete disappearance of the tumor cells have been detected in the patients who have been treated with combination of lymphodepletion with anti-CD30 CAR-T cells. Several different benefits associated with the therapy were achieved in the patients with respect to cli...
Read More
Recent Advances in the Treatment Leading to Decline in the Overall Lung Cancer Mortality Rate
Release Date: 07 August 2020
In the past few years, there has been increasing cases related to lung cancer cases and deaths related to it. Therefore, controlling the cancer is one of the major concerns for majority of the researchers all around the world. But this has now been taken into conside...
Read More
Novel Immunotherapy Combination Therapy for Advanced Skin Cancer
Release Date: 06 August 2020
Malignant melanoma is a type of cancer that needs special assistance and therapy. In majority of the patients who have been treated with single therapy do not respond well to the therapies therefore, it was important to treat the cancer two a combination of therapy t...
Read More
FT819 CAR T-cell Therapy Approved for Leukemia and Lymphome Clinial Trials
Release Date: 06 August 2020
The US FDA approved Fate Therapeutics investigational drug candidate called as FT819 for the clinical testing for the indication – leukemia and lymphoma. The trial will be focsuded towards determining the maxmimum tolerated dose, safety and clinical activity of...
Read More
Intensity-Modulated Radiotherapy, 3-Dimensional Conformal Radiotherapy, or Proton Beam Radiotherapy Analysis for Second Cancer Diagnosis Risk
Release Date: 05 August 2020
The study follows evaluating the risk of second cancer diagnosis after the primary treatment which was followed by the use of proton beam radiotherapy, intensity-modulated radiotherapy and 3-dimensional conformal radiotherapy. It was found that the risk of second can...
Read More
Two Cutting-Edge Technologies to Guide Through Cancer Treatment Decisions Entering Legal Implications
Release Date: 05 August 2020
Recently, the US FDA has approved two novel technologies in order to help the physicians to guide them through the process of cancer treatment. The two cutting end technologies in one tool are next-generation sequencing and liquid biopsy (uardant Health’s Guard...
Read More
AURKB Protein to Control Idiopathic Pulmonary Fibrosis in Mice Model Organsims
Release Date: 04 August 2020
AstraZeneca investigated AURKB protein that was found to be easing the activation of fibroblast and lung scarring in the model organism (mouse) having idiopathic pulmonary fibrosis. The primary aim of the study was to identift the drug barasertic as an anti-fibrotic ...
Read More
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
14 |
15 |
16 |
17 |
18 |
19 |
20 |
21 |
22 |
23 |
24 |
25 |
26 |
27 |
28 |
29 |
30 |
31 |
32 |
33 |
34 |
35 |
36 |
37 |
38 |
39 |
40 |
41 |
42 |
43 |
44 |
45 |
46 |
47 |
48 |
49 |
50 |
51 |
52 |
53 |
54 |
55 |
